Although a trend towards better anatomic and visual outcomes was identified among patients taking aqueous suppressants, most of these differences did not reach statistical significance. 17 The current study sought to determine whether treatment courses differed during the first year of therapy among patients with exudative AMD based on their use of ocular hypotensive agents.
← all excerpts
Treatment Course of Patients with Exudative Age-Related Macular Degeneration Using Ocular Hypotensives.
1
—
—